Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.59 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ICMT | O60725 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL244918 | 0.86 | KMT2A (0.42) | MTNR1AMTNR1BKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL6259332 | 0.85 | MAPT (0.49) | MTNR1AMTNR1BKMT2ASMN1; SMN2RAB9A | |
| SCHEMBL27677191 | 0.85 | KMT2A (0.41) | MTNR1AMTNR1BKMT2AMEN1SMN1; SMN2 | |
| Water SCHEMBL20853621 | 0.84 | KMT2A (0.41) | MTNR1AMTNR1BKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL917492 | 0.83 | GAA (0.59) | KMT2AMEN1SMN1; SMN2GAARAB9A | |
| SCHEMBL6404606 | 0.83 | MTNR1A (0.56) | MTNR1AMTNR1BKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL5587045 | 0.83 | KMT2A (0.42) | MTNR1AMTNR1BKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL12311324 | 0.83 | MTNR1A (0.53) | MTNR1AMTNR1BKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL11114174 | 0.82 | MTNR1A (0.66) | MTNR1AMTNR1BKMT2AMEN1GAA | |
| SCHEMBL1897682 | 0.82 | MAPT (0.61) | KMT2AMEN1GAAICMTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012168470-A1 | METHOD FOR THE DETERMINATION OF THE CONCENTRATION OF VITAMIN B6 IN A SAMPLE | BÜHLMANN LABORATORIES AG (CH) | 2012-12-13 | — | — | WO | claimed |
| CN-118302536-A | Reagent composition and kit | 电化株式会社 | 2024-07-05 | — | — | CN | disclosed |
| EP-4029949-B1 | KIT AND A METHOD FOR QUANTIFYING SMALL DENSE LDL CHOLESTEROL (SDLDL-C) IN A SAMPLE | DENKA COMPANY LTD (JP) | 2024-07-03 | — | — | EP | disclosed |
| CN-112074743-B | Method, reagent and kit for quantifying lipoprotein cholesterol | 电化株式会社 | 2024-04-12 | — | — | CN | disclosed |
| EP-4328320-A1 | REAGENT COMPOSITION AND KIT | Denka Company Limited (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-117203347-A | Reagent composition and kit | 电化株式会社 | 2023-12-08 | — | — | CN | disclosed |
| EP-3467120-B1 | METHOD AND REAGENT FOR QUANTIFYING CHOLESTEROL IN TRIGLYCERIDE-RICH LIPOPROTEIN | DENKA COMPANY LTD (JP) | 2023-11-08 | — | — | EP | disclosed |
| WO-2023199890-A1 | REAGENT COMPOSITION AND KIT | デンカ株式会社 | 2023-10-19 | — | — | WO | disclosed |
| US-20230313266-A1 | METHOD AND KIT FOR QUANTIFICATION OF LIPOPROTEIN CHOLESTEROL | DENKA COMPANY LIMITED (JP) | 2023-10-05 | — | — | US | disclosed |
| CN-109312389-B | Method for quantifying cholesterol in triglyceride-rich lipoprotein and quantification reagent | 电化株式会社 | 2023-09-19 | — | — | CN | disclosed |
| EP-2116612-A1 | REAGENT FOR DETERMINATION OF QUANTITY OF SMALL DENSE LOW-DENSITY LIPOPROTEIN | DENKA SEIKEN Co., Ltd. (JP) | 2009-11-11 | — | — | EP | disclosed |
| US-20090263844-A1 | METHOD AND KIT FOR QUANTITATIVE DETERMINATION FOR SMALL, DENSE PARTICLE LOW DENSITY LIPOPROTEINS | DENKA SEIKEN CO., LTD. (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-1930442-A1 | METHOD AND KIT FOR QUANTITATIVE DETERMINATION FOR SMALL, DENSE PARTICLE LOW DENSITY LIPOPROTEINS | DENKA SEIKEN Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20040247629-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | L'OREAL | 2004-12-09 | — | — | US | disclosed |
| US-6572870-B2 | Mixture containing oils, lipids and surfactants | L'OREAL (FR) | 2003-06-03 | — | — | US | disclosed |
| US-20010055601-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | L'OREAL | 2001-12-27 | — | — | US | disclosed |
| US-6319508-B1 | ANHYDROUS COSMETIC MAKEUP COMPOSITION FOR APPLICATION TO SKIN OR LIPS CONSISTING ESSENTIALLY OF MIXTURE OF FATTY PHASE AND PROVESICULAR LIPID PHASE ALSO CONTAINING AT LEAST ONE COSMETIC AND/OR DERMOPHARMACEUTICAL ACTIVE MATERIAL | L'OREAL (FR) | 2001-11-20 | — | — | US | disclosed |
| EP-0398941-A4 | DRY POWDER DIAGNOSTIC REAGENT AND APPLICATIONS THEREOF | — | 1991-04-10 | — | — | EP | disclosed |
| EP-0398941-A1 | DRY POWDER DIAGNOSTIC REAGENT AND APPLICATIONS THEREOF | BOEHRINGER MANNHEIM CORPORATION (US) | 1990-11-28 | — | — | EP | disclosed |
| WO-1989006284-A1 | DRY POWDER DIAGNOSTIC REAGENT AND APPLICATIONS THEREOF | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010055601-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | FABP4, CUTA, LIPA | MTNR1A 3827/4885MTNR1B 3950/4885KMT2A 3327/4885 |
| US-20040247629-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | FABP4, CUTA, LIPA | MTNR1A 3827/4885MTNR1B 3950/4885KMT2A 3327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.